Pfizer Inc. has entered into a five-year corporate integrity agreement as part of a settlement with the Department of Justice to resolve claims it used a foundation as a conduit to fund the copays of Medicare patients taking three of its drugs in violation of the Anti-Kickback Statute and the False Claims Act.
The corporate integrity agreement (CIA) with HHS' Office of Inspector General requires Pfizer to retain an independent review organization to assist the company in evaluating its systems, policies and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?